Lakefront Biotherapeutics (LKFT) EBIT Margin Growth (5y) (2019 - 2026)
Lakefront Biotherapeutics (LKFT) EBIT Margin Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Lakefront Biotherapeutics | 9.64 Bn | 9.64 Bn | 1.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -93,832.00 |
| Dec 31, 2025 | 11,774.00 |
| Sep 30, 2025 | -59,520.00 |
| Jun 30, 2025 | 32,927.00 |
| Mar 31, 2025 | -16,708.00 |
| Dec 31, 2024 | 19,287.00 |
| Sep 30, 2024 | -18,427.00 |
| Jun 30, 2024 | -32,812.00 |
| Mar 31, 2024 | 10,804.00 |
| Dec 31, 2023 | 3,482.00 |
| Sep 30, 2023 | -3,617.00 |
| Jun 30, 2023 | 4,545.00 |
| Mar 31, 2023 | 6,027.00 |
| Dec 31, 2022 | 3,768.00 |
| Sep 30, 2022 | 8,246.00 |
| Mar 31, 2022 | 1,751.00 |
| Dec 31, 2021 | -13,327.00 |
| Jun 30, 2021 | -920.00 |
| Mar 31, 2021 | 12,727.00 |
| Dec 31, 2020 | -70,652.00 |